Matthew Harrison
Stock Analyst at Morgan Stanley
(3.43)
# 930
Out of 4,937 analysts
695
Total ratings
48.94%
Success rate
3.12%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $460 → $439 | $366.54 | +19.77% | 41 | Aug 5, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $754 → $761 | $563.00 | +35.17% | 55 | Aug 4, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $146 → $144 | $130.67 | +10.20% | 54 | Aug 1, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $700 → $766 | $661.83 | +15.74% | 25 | Aug 1, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Equal-Weight | $15 → $20 | $18.23 | +9.71% | 38 | Jul 29, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $97 → $96 | $57.33 | +67.45% | 22 | Jul 22, 2025 | |
| INSM Insmed | Maintains: Overweight | $102 → $108 | $109.55 | -1.41% | 18 | Jul 17, 2025 | |
| R Ryder System | Initiates: Positive | $215 | $177.70 | +20.99% | 1 | Jul 15, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $80 → $81 | $37.00 | +118.92% | 12 | Jul 10, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $130 → $135 | $119.41 | +13.06% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.38 | +77.51% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $39 → $32 | $26.12 | +22.51% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.67 | +647.50% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $41 → $33 | $13.96 | +136.39% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $153.13 | +16.24% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $32.86 | +70.42% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $31.67 | +73.67% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $2.15 | +39.53% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $1.81 | +231.49% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $17.02 | -35.37% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.44 | +455.56% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.21 | +216.74% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $20.15 | +68.73% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $21.43 | +49.32% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.79 | +401.98% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.80 | +25.33% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $18.34 | -45.47% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $6.49 | +23.36% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $32.54 | +35.24% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.00 | +333.33% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $10.98 | +628.60% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.56 | +979.14% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $111.66 | +93.44% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $2.68 | +86.57% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.25 | +122.22% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $198.05 | -8.10% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $7.93 | +13.56% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $50.46 | -20.73% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $288.23 | -2.16% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $438.93 | -52.16% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $24.58 | +111.55% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $173.33 | -0.19% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $27.54 | +335.73% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $14.74 | +904.07% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $80.69 | +1.62% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $45.95 | +43.63% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $2.72 | +1,333.82% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $37.58 | +22.41% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $9.22 | +279.61% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $625.65 | -56.05% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.38 | +698.32% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $7.85 | +689.81% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.09 | +7.21% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $78.39 | +5.88% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $34.11 | -70.68% | 4 | Sep 10, 2018 |
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $366.54
Upside: +19.77%
Regeneron Pharmaceuticals
Aug 4, 2025
Maintains: Overweight
Price Target: $754 → $761
Current: $563.00
Upside: +35.17%
Biogen
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $146 → $144
Current: $130.67
Upside: +10.20%
argenx SE
Aug 1, 2025
Maintains: Overweight
Price Target: $700 → $766
Current: $661.83
Upside: +15.74%
Sarepta Therapeutics
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $18.23
Upside: +9.71%
BioMarin Pharmaceutical
Jul 22, 2025
Maintains: Overweight
Price Target: $97 → $96
Current: $57.33
Upside: +67.45%
Insmed
Jul 17, 2025
Maintains: Overweight
Price Target: $102 → $108
Current: $109.55
Upside: -1.41%
Ryder System
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $177.70
Upside: +20.99%
Legend Biotech
Jul 10, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $37.00
Upside: +118.92%
Gilead Sciences
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $119.41
Upside: +13.06%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.38
Upside: +77.51%
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $26.12
Upside: +22.51%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.67
Upside: +647.50%
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $13.96
Upside: +136.39%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $153.13
Upside: +16.24%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $32.86
Upside: +70.42%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $31.67
Upside: +73.67%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $2.15
Upside: +39.53%
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $1.81
Upside: +231.49%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $17.02
Upside: -35.37%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.44
Upside: +455.56%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.21
Upside: +216.74%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $20.15
Upside: +68.73%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $21.43
Upside: +49.32%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.79
Upside: +401.98%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.80
Upside: +25.33%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $18.34
Upside: -45.47%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $6.49
Upside: +23.36%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $32.54
Upside: +35.24%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.00
Upside: +333.33%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $10.98
Upside: +628.60%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.56
Upside: +979.14%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $111.66
Upside: +93.44%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.68
Upside: +86.57%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.25
Upside: +122.22%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $198.05
Upside: -8.10%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $7.93
Upside: +13.56%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $50.46
Upside: -20.73%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $288.23
Upside: -2.16%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $438.93
Upside: -52.16%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $24.58
Upside: +111.55%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $173.33
Upside: -0.19%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $27.54
Upside: +335.73%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $14.74
Upside: +904.07%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $80.69
Upside: +1.62%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $45.95
Upside: +43.63%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $2.72
Upside: +1,333.82%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $37.58
Upside: +22.41%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $9.22
Upside: +279.61%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $625.65
Upside: -56.05%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.38
Upside: +698.32%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $7.85
Upside: +689.81%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.09
Upside: +7.21%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $78.39
Upside: +5.88%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $34.11
Upside: -70.68%